Evidence map›Paper›PMID 40115811›Full record

ArticleJournal of pharmaceutical analysis2025

Rapid enrichment and SERS differentiation of various bacteria in skin interstitial fluid by 4-MPBA-AuNPs-functionalized hydrogel microneedles.

Ying Yang, Xingyu Wang, Yexin Hu, Zhongyao Liu, Xiao Ma, Feng Feng, Feng Zheng, Xinlin Guo, Wenyuan Liu, Wenting Liao and 1 more

Abstract read
In one paragraph

Article in Journal of pharmaceutical analysis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. DMikrochimica acta · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ying YangDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.
Xingyu WangDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.
Yexin HuDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.
Zhongyao LiuDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.
Xiao MaGansu Institute for Drug Control, Lanzhou, Gansu, 730000, China.
Feng FengSchool of Pharmacy, Nanjing Medical University, Nanjing, 211166, China.
Feng ZhengDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.
Xinlin GuoSchool of Chemistry, University of Manchester, Manchester, M13 9PL, UK.
Wenyuan LiuDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.
Wenting LiaoDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.
Lingfei HanDepartment of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, 211198, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial infection is a major threat to global public health, and can cause serious diseases such as bacterial skin infection and foodborne diseases. It is essential to develop a new method to rapidly diagnose clinical multiple bacterial infections and monitor food microbial contamination in production sites in real-time. In this work, we developed a 4-mercaptophenylboronic acid gold nanoparticles (4-MPBA-AuNPs)-functionalized hydrogel microneedle (MPBA-H-MN) for bacteria detection in skin interstitial fluid. MPBA-H-MN could conveniently capture and enrich a variety of bacteria within 5 min. Surface enhanced Raman spectroscopy (SERS) detection was then performed and combined with machine learning technology to distinguish and identify a variety of bacteria. Overall, the capture efficiency of this method exceeded 50%. In the concentration range of 1 × 10

Indexed as

Broad-spectrum bacteria detectionHydrogel microneedleMachine learningSERSSkin interstitial fluid

Identifiers

PMID40115811
PMCPMC11925168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.